Anemia  >>  cyclosporine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
MINI HEME, NCT00636909: Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

Completed
2
25
NA
Cyclophosphamide, fludarabine, cyclosporine, methotrexate, G-CSF
Beth Israel Deaconess Medical Center, Amgen
AML, ALL, CML Chronic Phase, Accelerated Phase, or Blast Crisis, CLL, MDS, RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA, APLASTIC ANEMIA, MULTIPLE MYELOMA, MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)
03/06
 
NCT00533923: Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

Completed
2
25
US
Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF, Cytoxan;, Fludara;, Leukine;
Beth Israel Deaconess Medical Center, Bayer
AML, ALL, CLL, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma, Aplastic Anemia, Myeloproliferative Disorder
01/07
01/07
RATGAA07, NCT00471848 / 2007-000902-55: Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia

Completed
2
35
Europe, RoW
rabbit antithymocyte globulin, Thymoglobuline
European Society for Blood and Marrow Transplantation, Genzyme, a Sanofi Company
Aplastic Anemia
10/11
02/13
SOAR, NCT02998645 / 2016-002814-29: Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

Completed
2
54
Europe, RoW
eltrombopag, ETB115, Cyclosporine
Novartis Pharmaceuticals
Severe Aplastic Anemia
11/20
05/22
NCT05797623: Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia

Recruiting
2
78
RoW
Trappa ethanolamine tablets ; ciclosporin, Placebo ; ciclosporin
Jiangsu HengRui Medicine Co., Ltd.
Non-severe Aplastic Anemia
05/24
05/25
NCT01623167: Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Recruiting
1/2
207
US
Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Horse Antithymocyte Globulin, Cyclosporine, Promacta, Eltrombopag, Cohort 2: hATG, CsA, EPAG Day 14 to Month 3, Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6, Extension Cohort, Horse Antithymocyte Globulin (hATG), Cyclosporine (CsA), Promacta, Eltrombopag (EPAG)
National Heart, Lung, and Blood Institute (NHLBI), Novartis
Severe Aplastic Anemia
01/18
01/29

Download Options